Friday 30 December 2016

Skincare Devices Market 2023; Increasing Incidence of Skin Cancer Boosts Sales

The market overview section of the report includes qualitative analysis of the overall skincare devices market, including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces Analysis. The increasing global incidence of skin cancers coupled with the rising disposable incomes of patients is propelling the uptake of skincare devices. However, the competitive pricing and higher equipment costs are set to restrain the market during the forecast period. Additionally, the report contains market attractiveness analysis by geography and competitive landscape by key players. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
As per Transparency Market Research (TMR), the global skincare devices market is expected to surge at a CAGR of 10.1% between 2015 and 2023. TMR has pegged the market to reach a valuation of US$17,299.4 mn in 2023, from US$7,255.8 in 2014.
North America Emerges as Most Lucrative Regional Market for Skincare Devices
Regionally, emerging economies in Latin America, Eastern Europe, and Asia have been exhibiting the most lucrative prospects for the sale of skincare devices. As of 2014, North America had emerged dominant in the global skincare devices market, trailed by Europe. TMR projects the North America skincare devices market to surge at a CAGR of 9.92% during the forecast period. The region in 2014 held 44.4% of the overall market.
The sale of skincare devices in North America is substantially bolstered by the increasing population of baby boomers in the region. Besides this, the rising aesthetic needs and increasing awareness among customers about their health and well-being have augmented demand for high-performing skincare devices in the region. Technical product developments, paradigm shift in consumer preferences towards non-invasive skincare procedures, and the increasing incidence of skin cancer are other factors fuelling demand for advanced skincare devices from North America.
Asia Pacific however is expected to showcase the highest CAGR of 11.78% during the forecast period. The promising growth in the skincare devices market of the region is attributable largely to the presence of a large population with unmet demand for beauty and wellness.
Increasing Incidence of Cellulite to Fuel Demand for Skincare Devices
Based on application, demand for skincare devices was witnessed to be the highest for cellulite reduction. The segment accounted for a share of 25.1% in 2023. However, during the forecast period, the skin tightening and body contouring segment will exhibit growth at the fastest pace in the market. As per TMR nearly 85% to 98% women are affected by cellulite every year globally. Despite its increasing incidence, cellulite is considered to be an issue of worry by millions of women around the world. Cellulite reduction is thus seen as the largest application segment in the market mainly because of the alarming rise of obesity worldwide, the increasing demand for non-invasive beauty procedures, and increasing willingness of consumers to spend on their beauty and wellness.
Apart from their increasing usage in cellulite reduction, skincare devices are also used for diagnosis and treatment of various skin diseases such as skin cancer, warts, fungal infections, psoriasis, scabies, and others.
Some of the most prominent enterprises operating in the market include Lumenis Ltd., Valeant Pharmaceuticals, Cynosure, ZELTIQ Aesthetics, Inc., and Syneron Medical Ltd.
Posted by at No comments:
Labels: , , , ,

Cone Beam Computed Tomography Market valuation of this market will be worth US$960.8 mn by 2023

Efficiency of CBCT Technologies Increases their Adoption
The rising geriatric population and their slew of medical needs will be the undercurrent defining the trajectory of the global cone beam computed tomography market. The unmet dental needs of the gaining population across the globe will play a crucial part in steering this market to its warranted revenues. The ability to offer three-dimensional visuals of teeth, roots, and other important parts of a jawline will prove to exceptionally useful in managing several dental conditions and diseases amongst the elderly population spread in the world. According to the research report published by Transparency Market Research (TMR), the opportunity in the global CBCT market was worth US$407.5 mn in 2014. However, analysts predict that the valuation of this market will be worth US$960.8 mn by 2023 as it expands at a steady CAGR of 10.0% between 2015 and 2023.
In recent years, the demand for CBCT technology has skyrocketed due to increasing affordability of advanced computers equipped with CBCT units. Several dentists and imaging specialists are not only using but also advising the use of CBCT technologies to determine the problem with absolute clarity. Thus, the effectiveness and the efficiency brought in by CBCT technologies in medical interventions is driving the overall market in top gear.
Excise Norms Could Dissuade Market Growth in Key Regions
Despite the promising market drivers, the applications of CBCT technologies in dental implants, orthodontics, endodontics, oral surgeries, and general dental surgeries is being overshadowed by stringent excise norms. This restraint is predominant in the U.S. market where the excise duty on import makes dental treatment and usage of CBCT technology largely unaffordable. This constraint is further aggravated by low adoption rate of digitalized technologies by old school medical practitioners who are still resorting to old-fashioned diagnostics.
Currently, the oral surgery segment is making the maximum usage of CBCT technologies. As of 2015, the oral surgery segment accounted for a share of 26.4% in the overall market. This segment is estimated to rise at a phenomenal pace in the forecast period as CBCT scanners have brought a remarkable advancement in maxillofacial and oral imaging.
Asia Pacific CBCT Market to Grow Phenomenally
Research suggests that Asia Pacific has been progressing at an unprecedented pace due to an ever-increasing pool of geriatrics and thus a high prevalence of dental issues. However, North America was reported to the largest geographical segment in the overall market due to its well-established infrastructure for healthcare, high adoption of dental imaging technologies, and a developed market.
The important players operating in the global CBCT market are Sirona Dental Systems, Cefla Group, Carestream Health, QR s.r.l., VATECH Global Co. Ltd., Danaher Corporation, Planmeca OY, and Prexion, Inc. The majority of the players will focus on increasing their product portfolio and expanding their reach to the consumers to grab bigger market shares in the foreseeable future. Furthermore, analysts also predict strategic business partnerships and expanding product portfolio will be integral to the growth of these individual players in the near future.
Posted by at No comments:
Labels: , ,

Global Blood Pressure Monitoring Devices Market to Gain Impetus from Growing Prevalence of Hypertension

The competitive landscape of the global blood pressure monitoring devices market is dominated by companies with a diverse product catalog and expansive presence across various regions. Omron Healthcare, Welch Allyn, Philips Healthcare, Shenzhen Kingyield Technology, Panasonic, Contec Medical Systems, and A&D Medical. According to Transparency Market Research, the top five companies in the global blood pressure monitoring devices market accounted for 55% of the market in 2014, indicating a high degree of consolidation that is only likely to increase in the coming years.
The sustained product development efforts carried out by major players in the blood pressure monitoring devices market have led to a market marked by price-based competition. This has given large companies an edge over new entrants and specialist companies, which is likely to result in significant M&A activity in the blood pressure monitoring devices market in the coming years.
According to Transparency Market Research, the global blood pressure monitoring devices market was valued at US$2 bn in 2014. It is likely to exhibit a strong 7.30% CAGR from 2015 to 2023 and rise to a valuation of US$3.8 bn.
Home-based Healthcare to Remain Leading End User of Blood Pressure Monitoring Devices
The key end users of blood pressure monitoring devices are hospitals and patients availing home care facilities. The latter is likely to remain the leading contributor to the global market, with the valuation of the home care segment being almost twice that of the hospitals segment. The use of blood pressure monitoring devices in home care has been driven by the rising prevalence of hypertension and other lifestyle conditions that don’t necessarily require hospitalization but do necessitate continuous monitoring.
The incorporation of blood pressure monitoring devices in home care has also been helped by the steady product innovation in the industry. This has resulted in the production of reliable and efficient blood pressure monitoring devices, which has helped increase patient confidence. Due to the relatively simple fundamental nature of blood pressure monitoring devices, product innovation and price reductions have become the key strategies for manufacturers, which has helped drive the demand for blood pressure monitoring devices.
Unfavorable Reimbursement Policies Restrict Adoption of Blood Pressure Monitoring Devices
Despite the significant demand from hospitals as well as home care initiatives, reimbursement support for blood pressure monitoring devices is lacking in many countries. This is the key restraint on the blood pressure monitoring devices, as the increasing popularity of home healthcare means the reimbursement frameworks will need to be rearranged to reflect the increasing demand for blood pressure monitoring devices.
Asia Pacific Set to Dominate Blood Pressure Monitoring Devices Market
In 2014, North America was the dominant contributor to the global blood pressure monitoring devices market due to the presence of several leading international players, the increasing prevalence of blood pressure disorders, and the widespread availability of blood pressure monitoring kiosks for public use. The increasing deployment of blood pressure monitoring kiosks, which are becoming common in shopping complexes and other public areas in developed countries, has significant potential to drive the demand for blood pressure monitoring devices in North America and parts of Western Europe in the coming years.
On the other hand, the immense potential of Asia Pacific, thanks to its large population base and the formidable presence of unmet medical needs, has encouraged several manufacturers of blood pressure monitoring devices to focus on it as a market for the present as well as the future. While Asia Pacific trails the North America market at present, it is expected to catch up with it over the 2015-2023 forecast period and emerge as a leading contributor to the global blood pressure monitoring devices market.
The information in this preview comes from a Transparency Market Research report titled ‘Blood Pressure Monitoring Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2023.’
Posted by at No comments:
Labels: , ,

Big Expectations for the future of Dental Laboratories Market

Transparency Market Research has published a new market report titled, “Dental Laboratories Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.” According to the report, the global dental laboratories market was valued at US$ 12,991.6 Mn in 2014 and is projected to expand at a CAGR of 4.9% from 2015 to 2023 to reach US$ 20,234.1 Mn in 2023.
Dental laboratories are an amalgamation of art, science, and technology required for designing and manufacturing of products as a replacement of natural teeth. The scope of the research encompasses development of products such as crowns, bridges, caps, veneers, and other orthodontic splints and appliances essential to protect and straighten teeth. Similar to other areas/domains of the health care industry, the dentistry segment has witnessed significant growth over the past few years. Introduction of novel technologies and innovative materials have also attributed to the evolution of the dental laboratories market.
Geographically, the global dental laboratories market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. Each region has been further analyzed and estimated for major contributing countries. For instance, North America includes the U.S. and Canada. Europe has been sub-categorized into the U.K., Germany, France, Spain, Italy, and Rest of Europe. Asia Pacific includes China, Japan, and Rest of Asia Pacific. Rest of the World has been studied and segmented into Latin America and Middle East & Africa.
Europe accounted for the lion’s share of the global dental laboratories market in 2014, followed by North America. A number of community-based oral health programs are conducted across the European Union that focus on delivery of preventive treatment, increase awareness, and enhance patient education toward various procedures and artificial dental products, which over the past few years have contributed to the growth of the dental laboratory industry. However, Asia Pacific is expected to outperform the two major contributing regions during the forecast period from 2015 to 2023. Growth of the market in Asia Pacific is primarily driven by rising trend of dental tourism and increase in the number of laboratories established in the last five years. Moreover, the market is projected to expand at a substantial growth rate due to increase in export demand for dental orthodontic, periodontics, crowns, bridges, and implants from emerging markets such as India and China. Health care provision in Africa is challenged by the burden of poverty and underdevelopment, with 80% of the population falling into the lowest socioeconomic category. Lack of financial and technical resources, shortage of health personnel, and insufficient primary health care delivery make it hard for most of the population of Africa to access basic health services. Shortage of oral health personnel is a common problem in Africa, as the average dentist to population ratio is approximately 1:150000 compared to 1:2000 in most developed economic countries.
Lack of proper reimbursement and high operational cost are the major restraints of the global dental laboratory industry. To operate a dental laboratory, around 40% to 60% of what a dentist pays goes toward the expense of running a modern dental practice. Additionally, pay for rent or mortgage payments on their office space, payroll for hygienists, office managers and receptionists, health insurance, taxes, supplies, business insurance, and technology are the other expense burdens on laboratory owners. High operational cost, intense competition, and restricted geographical reach are among the primary reasons for closure of large number of dental laboratories in the past few years that is common in both developed and emerging markets.
Advent of CAD/CAM technology has significantly reduced the design and manufacturing time for dental prosthesis such as crowns and bridges. 3D imaging techniques have improved patient diagnosis and procedure planning; hence are considered to be other factors driving sustained growth and demand for dental laboratories and services offered to dentists. Rising costs and declining insurance reimbursements have created high demand for outsourced dental laboratories work. Currently, approximately 40% to 50% dental laboratories in the U.S. use off-shore laboratory services to produce components and/or complete dental laboratory services such as crowns, bridges, single porcelain fused to gold, complete dentures, partials, and frameworks.
Key players operating in this market are 3M Health Care, Danaher Corporation, Dentcare Dental Lab, Henry Schein, Inc., Institut Straumann AG, Keating Dental Arts, Modern Dental Laboratory Co., Ltd., National Dentex Corporation, Patterson Companies, Inc., Shofu, Inc., Sirona Dental Systems, and Yenadent Ltd. Sti.
Posted by at No comments:
Labels: , , ,

Ultraviolet Germicidal Irradiation Market: Business Challenges, Emerging Technologies & Competitive Landscape

The Transparency Market Research report on the global ultraviolet germicidal irradiation market states that this market will be worth US$430.3 mn by 2023 from US$168.4 mn in 2014, expanding at a CAGR of 10.9% from 2015 to 2023. The growing awareness amongst consumers about advanced food packaging techniques and hygienic surroundings are augmenting the global UVGI market at a steady pace. This market is also thriving due to the stringent regulations laid down by governments about purity standards and need to control the spread of diseases.
The key players holding the lion’s share in the global ultraviolet germicidal irradiation market are America Ultraviolet, GE Water & Process Technologies, and UltraViolet Devices, Inc. amongst others, TMR finds in a new report. The majority of these companies will focus on offering effective and cost-efficient products to tap the unmet needs in the overall market. For instance, GE Water & Process Technologies is adopting advanced H-technology to improve its line of products and services to gain a competitive edge in the overall vendor landscape. The global UVGI market will also witness a broader range of products in the coming years to appeal to a wider segment of consumers.
Prevention of Diseases Augments UVGI Market
The noteworthy technological advancements in the UVGI systems have made them a popular choice for sterilization process in restaurants, air-conditioned offices, food joints, hospitals, and several manufacturing units. Consumers are opting for installing hi-tech UVGI systems in order to prevent the occurrence of dangerous airborne diseases, reducing the maintenance cost of HVAC, and mitigating the chances of microbial contamination through air vents.
The rising number of hospital-acquired infections (HAIs) is also driving the global UVI market. According to statistics published by the World Health Organization (WHO) in 2013, about seven patients out every 100 admitted in hospitals acquire HAIs. The global UVGI market will growth at an unprecedented rate against the backdrop of these factors.
Import-related Hurdles to Restrain Market
The biggest challenge faced by this market are the hurdles in developing countries to import UVGI systems. Furthermore, these countries also have a dearth of skilled labor that has the technical knowledge of installing and maintaining these systems. Therefore, the majority of the developing countries have to depend on outsourcing help, which increases the installation costs.
All of these factors are hampering the growth of the UVGI market in emerging economies. Global players are also suffering as several developing countries are formulating new policies to support local manufacturers. This shift in preference is setting a trend in countries of Latin America and Asia Pacific.
A TMR analyst states, “The global UVGI market does have a lineup of some lucrative opportunities such as the burgeoning demand from water purification and advanced packaging sector that are looking at ways to avert air and borne diseases.” The unfortunate reduction in sources of fresh water sources, water pollution, and air pollution have collectively created a demand for UVGI in the food and beverages packaging sectors.
Posted by at No comments:
Labels: , , ,

Medical Lifting Slings Market - An Emerging Worldwide Industry

According to a new market research report published by Transparency Market Research “Medical Lifting Slings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”, the global medical lifting slings market was valued at US$391.8 mn in 2015 and is estimated to reach US$910.6 mn in 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
Medical lifting slings are devices used in hospitals and nursing homes to transfer patients who have restricted mobility. The medical lifting slings market is driven by factors such as rising geriatric population, favorable government initiatives, and increasing incidence of lifestyle diseases. Moreover, increasing number of accidents and partial immobility incidences have fueled demand and growth of the market in the last decade. However, lack of technical expertise and proper training to handle patients with medical lifting slings in emerging economies coupled with difficulties in handling obese patients with lifting slings hampers market growth. The global medical lifting slings market was valued at US$391.8 mn in 2015 and is projected to reach US$910.6 mn by 2024, expanding at a CAGR of 9.2% from 2016 to 2024.
The universal sling segment dominated the medical lifting slings market in 2015. The dominance of this segment was majorly due to rising demand for universal lifting slings globally and comfortable and secure seating structure. The bariatric sling segment held the smallest share of the market in 2015 due to low average cost compared to other medical lifting sling products.
The universal sling segment is expected to gain market share in 2024 due to comfortable and secure seating structure. The transfer and toileting sling segment is likely to expand at a high CAGR during the forecast period. High growth rate of this segment is attributed to introduction of new supporting applications to provide better quality of life for patients and higher penetration in developing regions.
In terms of sling point, the 4 point sling segment held the largest share of the medical lifting slings market in 2015. The segment is expected to gain market share in 2024, as most products, such as bathing, spa, and hammock slings, fall under this segment. The u-shape sling segment is also estimated to witness strong growth during the forecast period as shorter lifespan results in purchase in large quantity by dealers.
The hospitals end-user segment accounted for the largest share of the market in 2015. The segment is expected to dominate the market during the forecast period. The dominance of the segment is primarily due to high adoption rate and government initiatives to train hospital nurses. Assisted living facilities and home health care have witnessed significant acceptance. Hence, the segment is likely to expand at the highest growth rate in the next few years
The global medical lifting slings market is fragmented, with the presence of many players in the market. Major players operating in the global medical lifting slings market are ArjoHuntleigh, Argo Medical, Inc., Bestcare, LLC, Drive DeVilbiss Healthcare, Etac AB, DJO Global, GF Health Products, Inc., Joerns Healthcare, LLC, Invacare Corporation, and Prism Medical, among others.
Posted by at No comments:
Labels: , , ,

Advanced (3D/4D) Visualization Systems Market: Future market projections for forthcoming years

The global advanced 3D/4D visualization systems market is dominated by some of the key companies such as Philips Healthcare, Toshiba, Siemens Healthcare, and GE Healthcare. These top companies collective dominated the global advanced 3D/4D visualization systems market by accounting for 39.4% in 2015. The global advanced 3D/4D visualization systems market is highly dynamic and competitive in nature with many new companies aiming to enter the competition. Going forward, the demand for higher technology 3D/4D visualization systems is expected to increase, which will increase the level of competition. Transparency Market Research (TMR), in a new report on this global market, states that the market is expected to be affected by the presence of substitutes for 3D/4D visualization systems.
The global advanced 3D/4D visualization systems market is predicted to reach US$3,280.0 mn by 2024. Based on platform, the global advanced 3D/4D visualization systems market is expected to be dominated by the CT segment as this segment is predicted to reach US$954.5 by 2024. Considering the rising demand, key companies are expected to introduce new 3D and 4D visualization systems in the global market so as to maintain their dominance throughout the forecast period.
Hospitals to Lead Demand for Advanced 3D/4D Visualization Systems
By end user, the global advanced 3D/4D visualization systems market was led by the hospital segment in 2015 and this segment is predicted to maintain its dominance throughout the forecast period. The hospital segment is expected to reach US$2,630.9 mn by 2024 owing to the rising number of hospitals demanding advanced 3D/4D visualization systems. Based on application, neurology led the global advanced 3D/4D visualization systems market in 2015. This segment is expected to maintain its dominance by 2024, to reach US%875.8 mn. The rising use of 3D and 4D visualization systems for conducting oncology procedures is predicted to propel this segment. Based on region, North America dominated the global advanced 3D/4D visualization systems market in 2015 and is predicted to maintain its dominance. The North America advanced 3D/4D visualization systems market is expected to reach US$1,052.9 by 2024.
Rising Medical Procedures to Propel Demand for 3D/4D Visualization Systems
The number of neurology, cardiology, oncology, and many other medical procedures is increasing in many of the emerging nations. “Medical procedures are conducted by using advanced quality 3D and 4D visualization systems, which is a boon for the global market,” says a TMR analyst. Advancements in the existing visualization systems and the rise in the demand for digitizing patient data are two of the other factors expected to benefit the global advanced 3D/4D visualization systems market.
Emergence of 5D Technology can Challenge Global Market
The introduction of 5D visualization technology has become possible because of the introduction of advanced technology. This is expected to be the biggest challenge for the global advanced 3D/4D visualization systems market. The high cost of equipment and the already existing investments in costly medical equipment can also hinder the growth of the global market for advanced 3D/4D visualization systems.
Untapped Market to Create Growth Opportunities
Emerging technologies and the untapped market can create new growth opportunities for the startups and key companies operating in the global advanced 3D/4D visualization systems market. The evolution of new advanced application for AV software is likely to benefit the global market for advanced 3D/4D visualization, says a TMR analyst.
This information is based on the findings of a report published by Transparency Market Research titled “Advanced (3D/4D) Visualization Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024.”
Posted by at No comments:
Labels: , , ,

Casting and Splinting (Supplies and Equipment) Market: Trends, Business Strategies and Opportunities with Key Players Analysis 2024

As per Transparency Market Research, the global casting and splinting market stood at US$1.8 bn in 2015. Rising at a CAGR of 6.1% between 2016 and 2024, the market is expected to reach US$3.1 bn by the end of 2024.
The global casting and splinting market exhibits the prevalence of intense competition as the presence of a large number of local and established players have rendered the market highly fragmented. As per Transparency Market Research (TMR), 3M healthcare, BSN Medical GmBH, Prime Medical, Inc., and Stryker Corporation constitute the leading companies in the casting and splinting market.
The most prominent companies in the market are currently focusing on strategic mergers and acquisitions to expand their presence globally. These enterprises are also vying to expand their businesses across emerging economies and increase their product offerings to gain the lion’s share in the market.
Rising Incidence of Accidents and Traumatic Injuries Creates Opportunities for Casts and Splints Sale
The demand for splint and casts is rising in response to the increasing incidence of orthopedic, sports, and musculoskeletal injuries globally. Since old people are more prone to injuries, the rising in geriatric population will boost opportunities for casts and splints sale. Furthermore, leading producers have started using advanced materials for manufacturing casts and splints in order to pace up with the evolution of technology. This has also helped in boosting the demand for casting and splinting supplies.
“However, unfavorable reimbursement policies and health insurance covers have been acting against the market’s growth prospects,” said a lead TMR analyst. “The lack of government as well as private insurance cover also limits opportunities for the market across developing countries such as India and Brazil,” he added.
Nevertheless, since there is little likelihood for the occurrence of road accidents and sports related to reduce in the near future, the demand for casting and splinting supplies is expected to remain high in Asia Pacific and Latin America. Besides this, the increasing incidence of orthopedic disorders, trauma, and injuries in developing countries such as India, Brazil, and China will provide considerably openings for vendors to capitalize on.
Demand for Splinting Supplies and Equipment Projected to Increase in Forthcoming Years
By products, the global casting and splinting market can be bifurcated into splinting supplies and equipment and casting supplies and equipment. Of these, the demand for casting equipment and supplies is projected to increase at a substantial pace. The segment also accounted for the dominant share in the market and is projected to rise at a CAGR of 5.6% between 2016 and 2024. In this segment, demand for cast cutters is expected to rise in the highest CAGR during the forecast period.
However, as per TMR analysis, growth exhibited by the splinting equipment and supplies segment is expected to be at a higher. Between 2016 and 2024, the splinting equipment and supplies segment is expected to rise to a CAGR of 6.9%. A large number of orthopedics are now preferring splints than casts because of better breathing offered by the former. Moreover, splints are also easier to apply, which is fuelling their demand globally.
Asia Pacific to Remain the Most Lucrative Market for Casts and Splints
Regionally, Asia Pacific has been demonstrating the most lucrative prospects for the global casting and splinting market. The region sealed its dominance in the global market with a share of 26.7% in 2015. As per TMR, due to the presence of a large number of cast and splint supplies manufacturers in Asia Pacific, the region is likely to continue its position as a market leader through the forecast period. The presence of a large pool of geriatric population, combined with the increasing awareness about osteoporosis, will boost the Asia Pacific casting and splinting supplies market at 6.9% from 2015 to 2024.
Prospects for the market in North America will also remain lucrative through the forecast period.
Posted by at No comments:
Labels: , , ,

Hearing Aids Market: High Prevalence of Hearing Impairment among Adults Fuels Demand

Early detection and treatment of hearing loss can mitigate the severity of deafness and could improve the condition of those suffering from the condition. As per World Health Organization, in 2015 the hearing aid production globally, hardly met 10% of the total need and a meager 3% of demand across developing countries. This provides the global hearing aids market with substantial opportunities to gain from in the forthcoming years.
As per Transparency Market Research (TMR), the global hearing aids market is expected to reach US$7.01 bn by 2024, from US$4.7 bn in 2015. Between 2016 and 2024, the global hearing aids market is thus expected to surge at a CAGR of 4.5%.
Increasing Geriatric Population and Awareness to Boost Sales of Hearing Aids
As aged people are more prone to develop hearing impairment, the sales of hearing aids are directly impacted by the current geriatric demographic dynamics in worldwide. In the last of few years, the awareness level among patients and their families regarding hearing impairment has considerably increased. This, combined with the recent advances in the hearing aid technology, is boosting sales of hearing aids worldwide. Furthermore, the advent of rechargeable hearing aids with long lasting and quick charging features will also augment the market’s growth.
Opportunities for the Market in Europe to be Most Lucrative
Regionally, Europe has been exhibiting the most attractive opportunities for companies in the hearing aids market. It emerged dominant with a share of 39% in the global market in 2015. The presence of a large pool of aged people across Western Europe and the increasing willingness among consumers to spend on advanced medical devices have helped Europe attain the lead in the global hearing aids market. The fact that several of the prominent names in the industry are domiciled in the region has also augured well for the market. TMR has pegged the value of the Europe hearing aids market at US$1.8 bn in 2015 and forecasts it to reach US$2.6 bn by the end of 2024, rising at a CAGR 4.1% from 2015 to 2024.
However, the market in Asia Pacific is expected to grow at a fast pace during the forecast period. The prevalence of considerably high unmet medical needs and the rising investment in the health care infrastructure create immense opportunities for sale of hearing aids in Asia Pacific. Besides this, governments across emerging economies are making considerable efforts to educate people about conditions such as health impairments have fuelled demand for hearing aids in the region. As per TMR, the regional market is expected to rise at a CAGR of 5.2% between 2016 and 2024.
Increasing Incidence of Hearing Loss in Children to Necessitate Development of New Products
By end user, the global hearing aids market is bifurcated into adult and pediatric. Of these, the adult segment held approximately 94.83% of the market in 2015.The incidence of hearing impairment is higher in developing and under-developed countries because of the high geriatric population in these countries. However, in the forecast period growth exhibited by the pediatric segment is expected to be faster due to the rising prevalence of hearing loss among children.
Key players in this market are Sonova AG (Switzerland), William Demant Holding (Denmark), Siemens Healthcare (Germany), GN ReSound A/S (Denmark), Starkey (U.S.), and Widex A/S (Denmark), among others.
Posted by at No comments:
Labels: , , , ,

Urolithiasis Management Devices Market expected to rise to US$1.78 bn up to 2024

The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the globe as well, factors such as obesity, rising geriatric population, which is highly susceptible to kidney stones owing to reduced renal function and diabetes, and change in lifestyles are contributing to increased prevalence of kidney stone formation.
Transparency Market Research estimates that the global urolithiasis management devices market will exhibit a healthy 4.5% CAGR over the period between 2016 and 2024 and rise to a valuation of US$1.78 bn by 2024.
Clinics and Ambulatory Surgical Centers to Remain Dominant End-use Segments
Of the key end-users of urolithiasis management devices, including hospitals, ambulatory surgery centers (ASCs), and clinics, the segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year. The leading position of the market segment can be attributed to factors such as the significant rise in the number of people opting for urolithiasis surgeries and advancements in treatment options that have reduced the time required for undertaking the procedures. Over the period between 2016 and 2024 as well, the segment is expected to hold a commanding position in the global market, retaining its status as the leading revenue generator.
The demand for urolithiasis management devices across ambulatory surgical centers is expected to exhibit a strong growth over the next few years, with the end-user segment emerging as one of the most promising investment grounds for the global urolithiasis management devices market. The segment is expected to exhibit strong growth owing to high demand for ambulatory surgical centers and preference for day care surgeries across developing as well as developed parts of the world. Applications of urolithiasis management devices across the hospitals end-use segment is expected to witness stagnant growth as clinics and ambulatory surgical settings become more preferred owing to the lower cost of treatment and the need to be hospitalized for shorter lengths of time.
Rising Geriatric Population in Asia Pacific to Stimulate Increased Adoption
North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Factors such as the rising prevalence of kidney stone, rising geriatric population, and campaigns undertaken to raise awareness about the risks associated with kidney stones by government bodies are central to the growth of the market in the region. Additionally, the introduction of new and innovative urolithiasis management devices such as laser lithotripters and flexible ureterenoscopes have also aided the healthy growth of the North America urolithiasis management devices market. The presence of high disposable income groups across developed economies such as the U.S. and Canada in North America, with a high prevalence of lifestyle-induced diseases such as obesity and a large base of geriatric population have also influenced the increased adoption of urolithiasis management devices.
The urolithiasis management devices market in Asia Pacific is expected to exhibit an impressive CAGR of 4.6% over the period between 2016 and 2024. The mounting geriatric population in the region is the key factor driving the urolithiasis management devices market in the next few years. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), is region is presently home to more than half of the world’s population of people aged over 60 years and the number is expected to rise to more than 2.45 bn by 2050. Owing to this, the regions is expected to lead to a substantial rise in demand for urolithiasis management devices in the next few years.
Some of the key vendors operating in the global urolithiasis management devices market are C. R. Bard, Inc., Allengers Medical Systems Ltd, Dornier Medtech GmbH, Boston Scientific Corporation, Cook Group, Inc., Electro Medical Systems S.A., DirexGroup, Olympus Corporation, Karl Storz, and Siemens Healthcare.
Posted by at No comments:
Labels: , , , , , ,

Thursday 29 December 2016

Compression Therapy Market: North America Exhibits Highest Prospects for Compression Therapy

Transparency Market Research forecasts the global compression therapy market to reach US$4.25 bn by 2024 from a valuation of US$2,693.4 mn in 2015. If these figures hold true, the market will exhibit a CAGR of 5.3% between 2016 and 2024.
Prevalence of Obesity Creates Ample Opportunities for Expansion of Compression Therapy Market in Developed Economies
The American Academy of Orthopedic Surgeons (AAOS) has stated that around 129,000 knee arthroplasty surgeries were conducted in the U.S. in 1990. The number had reached over 600,000 surgeries in 2010. Furthermore, the AAOS projects the number of arthroplasty surgeries to be conducted in the U.S. by 2030 to surpass 3 million. Considering the incredible rise in number of cases reported in the U.S. alone, the incidence of orthopedic conditions globally is projected to increase at a rapid pace. This creates ample opportunities for the expansion of the compression therapy market.
As obesity increases the risk of vascular diseases due to the pressure exerted by the bodyweight on underlying organs, its rising prevalence is often linked with the increasing demand for compression therapy. As per the World Health Organization (WHO), the prevalence of obesity has nearly doubled since 1980. With experts projecting the number to surge during the report’s forecast period, opportunities for the global compression therapy market are likely to bolster.
Lack of proper reimbursement policies will, however, limit the market’s success to an extent, finds TMR. Nevertheless, the rising investments in emerging economies and widespread unmet medical needs in these countries will support the market’s growth in the near future.
North America Emerges Dominant with Most Attractive Opportunities
Regionally, North America has been exhibiting the most lucrative prospects for leading enterprises in the market. The region held around 47.2% of the market in 2015, followed by Europe, which accounted for a share of 32.2% in the market in the same year. The prevalence of vascular diseases in both these regions is relatively higher. In North America, TMR finds the alarming rate of obesity as a prime driver of the compression therapy market. Among other regions exhibiting prospects for the compression therapy market, Asia Pacific is expected to report the highest CAGR.
Some of the prominent companies operating in the global compression therapy market include 3M Health Care, Bio Compression Systems, Inc., BSN Medical, Covidien plc, Paul Hartmann AG, and others.
Supported by Clinical Evidence, Static Compression Therapy Emerges as Dominant Market Segment
Demand for static compression therapy is forecast to rise at a rapid pace. The segment in 2015 held the largest share in the market and is expected to sustain its dominant position through the forecast period. The low cost and easy availability of static compression products have consequently boosted their sales. These products are also supported by clinical evidence, due to which doctors around the world seem to prefer static garments more. Besides this, the aesthetic appearance and comfortable material of static compression hosiery have made them a preferred choice among patients.
Posted by at No comments:
Labels: , , ,

Women’s Health Rehabilitation Products Market: Rising Geriatric Population Boosts Demand for Treat Urinary Incontinence Products

This research report provides a detailed analysis of the women’s health rehabilitation products market and helps understand various factors that drive the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. Porter’s Five Forces Analysis has been covered in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry in the global casting and splinting market. Value chain analysis and other market dynamics factors such as market attractiveness analysis have also been explained in order to deliver a thorough analysis of the overall competitive scenario of the global women’s health rehabilitation products market. This section of the report also includes key players’ product wise heat map analysis in 2015 for this market.
Surging at a CAGR of 5.0% between 2016 and 2024, the women’s health rehabilitation products market is expected to reach US$4.2 bn by 2024. The market stood at a valuation of US$2.6 bn in 2015.
Rehabilitation has emerged as an important method of mitigating the burgeoning risk of chronic diseases among women. These services are designed to improve the overall heart health, increase metabolism, expedite faster recovery, and improve hormonal profile among ailing women. Their demand has thus increased in response to the drastically changing lifestyle and dietary preferences. Integration of advanced technologies in existing rehabilitation products has further boosted prospects for their sales.
Earlier, acceptance of health rehabilitation services was a major issue across developed nations, which is now resolved with the rising awareness. However high product pricing still creates major bottlenecks for the sales of health rehabilitation products in emerging economies.
North America, Trailed by Europe, Emerged Key Contributors in 2015
Regionally, North America emerged as the key contributor in the global health rehabilitation products market in 2015, trailed by Europe. The market in North America is expected to reach US$1.5 bn by the end of 2024, from US$1 bn in 2015, rising at a CAGR of 4.9% during the period. High demand for women health rehabilitation products in both Europe and North America is attributed to the increasing number of road accidents in the last few years and the rising geriatric population. However, TMR projects Asia Pacific to exhibit the fastest CAGR due to the presence of untapped opportunities in the region. Besides this, Asia Pacific boasts a developing health care infrastructure and strong presence of skilled health care professionals, which is expected to drive demand for women health rehabilitation products in the region.
Rising Geriatric Population Boosts Demand for Treat Urinary Incontinence Products
By product type, orthopedic, pelvic pain product, urinary incontinence, pregnancy and postpartum, lymphedema, breast cancer, and osteoporosis constitute the major segments in the global women health rehabilitation products market. Of these, urinary incontinence held the dominant share in the market in 2015. It is also projected to maintain its lead through the forecast period. Increasing urinary incontinence among aged women is expected to keep demand from this segment high in the forthcoming years. The segment is expected to report a CAGR of 5.4% during the forecast period.
Some of the leading players operating in the global women health rehabilitation products market include Access Health (Victoria, Australia), Carib Rehab Ltd. (St. Michael, Barbados), GE Healthcare (Chalfont St. Giles, U.K.), GPC Medical Ltd.( New Delhi, India), Pelvic Health and Rehabilitation (San Francisco, U.S.), Rehab Plus (Timmins, Canada), Meyer Physical Therapy (New York, U.S.), Sportstek (Oakleigh, Australia), Vandana Surgical Cotton Ind. (Ajmer, India), and Win Health Medical Ltd. (Jedburgh, U.K.)
Posted by at No comments:
Labels: , ,

Tourniquet Market: Rising Number of Road Accidents Uphold Need for Tourniquet Systems in Emergency Healthcare Services

The tourniquet market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market which is divided by product, application, end-user and geography. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, and Porter’s Five Forces analysis providing a thorough analysis of the overall competitive scenario in the global tourniquet market.
A rising number of road accidents and government interventions aimed at improving the healthcare infrastructure in developing regions are the major factors that will provide major impetus to the global tourniquet market in the coming years.
Technological advancements and the introduction of disposable tourniquet cuffs will also play a major role in pushing the market further in the coming years. TMR findings project that the market holds an opportunity of US$408.6 mn by 2023. The market, which valued US$184.6 mn in 2014, will expand at a favorable CAGR of 9.3% over the period between 2015 and 2023.
Rising Concerns about Infections from Disposable Cuffs Prove Beneficial for Reusable Tourniquet Cuffs
The concerns about the risk of infection through the use of reusable tourniquet cuffs on multiple patients has been a major challenge for the global tourniquet market in the past years. The concerns have fared well for disposable tourniquet cuffs. Despite the fact that these products must be disposed of after single use, slightly adding to the overall costs of a surgery, are gaining increased adoption across several regional markets.
The market for disposable tourniquet cuffs is projected to exhibit a CAGR of 9.9% from 2015 to 2023. The segment of reusable tourniquet cuffs, cashing in on its immense popularity, will still manage to grow at a rather favorable 9.1% CAGR over the same period. Durability and cost-efficiency of reusable tourniquet cuffs will help the segment sustain through the tough times. Tourniquet systems, the devices that monitor inflation time of the cuff and regulate the pressure in response, will rise to a valuation of US$240.2 mn by 2023.
North America Leads due to Presence of Top Vendors and Increased Number of Accidents
On the geographic front, North America emerged as the clear leader in the tourniquet market in 2014, accounting for a share of 53.5%. The alarming rise in the number of road accidents and traumatic orthopedic injuries in the region helped the market achieve this monumental feat. Additionally, persistent attempts of government to improve awareness about the usage of technologically advanced tourniquet cuffs as an efficient first line of treatment have also supported the increased use of tourniquets across healthcare facilities in the region.
Europe acquired the second-largest, yet a comparatively modest 18.4%, share in the overall tourniquet market in 2014. Highly advanced emergency care infrastructure in the region is the major factor making Europe a promising regional market for tourniquet systems.
However, Asia Pacific will present the most lucrative growth opportunities for the global tourniquet market from 2015 to 2023. The rising population of the middle class demographic, increased healthcare funds, and the demand for technologically advanced trauma care products will help the Asia Pacific tourniquet market exhibit a 9.9% CAGR during this period. The tourniquet market in Asia Pacific will also benefit from the rising number of hospitals and laboratory settings, and the entry of several medical device companies in the region.
The highly dynamic and competitive global market for tourniquets features the presence of a large number of vendors. Zimmer Biomet Holdings, Inc. is the leading vendor, followed by Stryker Corporation and Ulrich GmbH & Co. These companies have their businesses across all three major segments of the global tourniquet market. Other major vendors in the market are Pyng Medical Corporation, Hammarplast Medical AB, Delfi Medical Innovation, Inc., and VBM Medizintechnik GmbH.
Posted by at No comments:
Labels: , , , ,

Global Medical Sensors Market: Development of IT-based Medical Sensor Devices to Emerge as Growth Opportunity, says TMR

The global medical sensors market is fragmented with the top three companies collectively accounting for 23.3% of the market in 2014. These three companies are Honeywell International Inc., Danaher Corporation, and NXP Semiconductors. Some of the other players in the market are GE Measurement & Control, Analog Devices, Inc., Omni Vision Technologies, Inc., TE Connectivity Ltd., and Avago Technologies Limited. Players in the market are intent on providing novel and advanced technology based medical sensors, states a new report by Transparency Market Research (TMR). It is expected that many local manufacturers will capture significant market shares. The absence of external substitutes will ensure a low level threat of substitutes.
According to the report, the global medical sensors market is expected to rise from US$10,000.0 mn in 2014 to US$18,741.3 mn by 2023. On the basis of product, the biosensors segment led in the past and will continue to do so, and be worth US$9,202.5 mn. However, the squid sensors segment will expand at the maximum CAGR of 8.6% from 2015 to 2023. On the basis of application, the surgical segment will continue to remain dominant and be worth US$6,259.6. In addition to this, it is expected that the monitoring segment will expand at a healthy CAGR of 8% from 2015 to 2023.
Asia Pacific to Emerge as Lucrative Regional Market for Medical Sensors in Future
By end user, the hospitals segment will lead and be worth US$5,809.9 mn by 2023. The nursing home and home care segment is expected to expand at a 7.8% CAGR between 2015 and 2023. On the basis of geography, North America is leading in the medical sensors market and will continue to do so. The market in North America is expected to be worth US$6,371.9 mn by 2023. On the other hand, Asia Pacific medical sensors market will prove to be lucrative in the coming years and expand at an 8.2% CAGR between 2015 and 2023. “The growing interest of key companies to expand their presence in the developing nations of Asia Pacific is expected to drive the market in the region”, says a TMR analyst.
High Risk of Various Diseases among Growing Geriatric Population to Drive Demand for Medical Sensors
The increasing prevalence of diseases such as obesity, diabetes, kidney, respiratory, and cardiovascular diseases is driving the global medical sensors market. Thus, there is a high demand for reliable and accurate medical equipment for the growing patient population, which in turn is boosting the market for medical sensors. Sensors help in giving early warnings and lead to an accurate diagnosis of diseases and thus, their need will continue to remain in the coming years. The growing population of elderly people worldwide will be another driving factor for the medical sensors market. With age, the chances of having orthopedic diseases, neurological disorders, endocrine diseases, and oral diseases increases and this will create a heightened demand for medical devices and surgeries where real time sensors play a vital role. On the other hand, the high cost of medical sensors will act as a restraint.
Emergence of IT-based Medical Devices to Create New Opportunities
The application of IT in medical industry has revolutionized treatment methods for various diseases. The introduction of medical electronics with features such as wireless and multimedia will create a heightened demand for medical sensors. Various players in the market are investing extensively in research and development so as to develop IT-based medical sensor devices. Moreover, IT has increased the scope of medical sensors in newer medical applications such as a digital pill or ingestible sensor pill for tracking drug delivery.
This information is based on the findings of a report published by Transparency Market Research titled “Medical Sensors Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019.”
Posted by at No comments:
Labels: , , , ,

Cerebrospinal Fluid (CSF) Management Market grows with growing medical tourism in emerging nations and rising geriatric population

Some of the key players in the global cerebrospinal fluid (CSF) management market are Medtronic plc, DePuy Synthes (a J & J Company), Sophysa S.A., Spiegelberg GmbH & Co. KG, B. Braun Melsungen AG, BeckerSmith Medical, Inc., Möller Medical GmbH, and Integra LifeSciences Holding Corporation. The global market for CFS management was valued at US$1.13 bn in 2014. Expanding at a healthy CAGR of 5.5% during the forecast period of 2015 to 2023, the revenue in the market is estimated to reach US$1.84 bn by the end of 2023.
In order to maintain their stronghold, these players actively focus on innovations and developments related to technology and application in the market for cerebrospinal fluid management in order serve the multi-dimensional needs of the consumers. For instance, Medtronic plc recently announced the clearance of StrataMR valves and shunts by the U.S. Food and Drug Administration (FDA). This is an addition to Medtronic portfolio of Strata Adjustable Valve Systems, which are used to treat patients with hydrocephalus and cerebrospinal fluid (CSF) disorders. The approval will help Medtronic to complete its portfolio of systems designed for access to full-body MRI, such as pacemakers, deep brain stimulation (DBS) systems, implantable cardioverter defibrillators (ICDs), and spinal cord stimulators.
Asia Pacific Emerging Lucrative Market
By type of product, the cerebrospinal fluid management market is segmented into CSF shunts and CSF drainage systems, which can be further sub-segmented into ventricular drainage system and lumbar drainage system. In 2014, CSF shunts were most in demand and, are expected to remain the dominant segment throughout the forecast period. Although, the segment of CSF drainage system is also projected for the strongest CAGR in the market. Geographically, the report studies the regional markets of North America, Europe, Asia Pacific, Latin America, and Rest of the World. North America contributed most of the demand for CSF management in 2014 and is likely to remain the most lucrative region during the forecast period. The report also rates Asia Pacific as a region that players could focus on, owing to factors such as increasing demand for minimally invasive surgeries, growing medical tourism in emerging nations, and rising geriatric population.
Increased Government Funding Supporting Growth
According to the United Nations (US), there were 841 million people aged over 60 in the world. The UN expects this number to exceed to 2 billion by the end of 2050. Since geriatrics generally suffer from neurological diseases such as Alzheimer’s and Parkinson’s, this exponential rise in geriatric population is the primary reason for the extending demand for CSF management. The report also observes overall rise in the incidences of neurological diseases, increased funding by government and private organizations, and the escalating demand for minimally invasive surgeries are some of the other factors that will support the growth rate in the global market for cerebrospinal fluid management. Conversely, risk of infection during surgery is expected to negatively influence the growth rate.
The author of the report concedes, “The countries with emerging economies such as China, India, and Brazil comprise profitable future markets for CSF management. These nations have vast populations and the disposable income among the urban population is on the rise, which is enhancing their purchasing power.”
The information presented in this review is based on a Transparency Market Research report, titled, “Cerebrospinal Fluid (CSF) Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.”
Posted by at No comments:
Labels: , ,

Monday 26 December 2016

Scleroderma Diagnostics and Therapeutics Market: Physician and Patient Preference to make Immunosuppressive Agents Leading Drug Category

TMR estimates that the global scleroderma diagnostics and therapeutics market will expand at a CAGR of 9.7% from 2016 to 2024 and rise from US$1,633.5 mn in 2015 to US$3,663.7 mn by 2024.
Global Scleroderma Diagnostics and Therapeutics Market: Snapshot
The scleroderma therapeutics and diagnostics market exhibits high potential due to untapped needs and is set to grow rapidly in the near future due to the increasing focus globally on treatment of orphan diseases. The lack of approved drugs in the market makes it a highly opportune condition for players to convert their innovative drug ideas into successful treatment methods for this rare chronic inflammatory disease.
Physician and Patient Preference to make Immunosuppressive Agents Leading Drug Category
Presently, there is no approved drug for treatment of this orphan disease. Although drugs to manage symptomatic relief are available in the scleroderma therapeutics market, the treatment of scleroderma is challenging for a physician, since no two patients are alike in the progress of their disease. Thus, a host of different drugs are prescribed to every patient, depending on the extent, severity and nature of their symptoms.
It has been observed that patient consumption patterns in the global scleroderma diagnostics and therapeutics market are inclined towards immunosuppressive agents, which have shown to provide relief against several symptoms in both systemic and localized scleroderma cases. Moreover, of the very few treatments identified to efficaciously modify the course of scleroderma, physicians often recommend immunosuppressive agents to manage the most common symptoms of the disease. The segment, as a result, accounts for the dominant share in the global market.
Prostacyclin analogues have been found to have a potent effect in treating systemic scleroderma patients who suffer from pulmonary arterial hypertension. However, these drugs are expensive and thus, even though a smaller sub-set of patients is administered with these agents, their market value is high. This segment grabbed over 8.0% share of the global scleroderma therapeutics market in 2015, and is anticipated to slightly decline by 2024 owing to availability of cheaper alternatives within this segment.
Developed Regions to Continue to Command Dominance
Owing to better diagnostic and treatment rates, in part due to proactive awareness-raising initiatives by various foundations, have aided North America and Europe gain the predominant share in the global scleroderma diagnostics and therapeutics market. North America accounted for a share of nearly 34.0% while Europe held nearly 30% of the global scleroderma therapeutics market in 2015. This is attributed to presence of renowned pharmaceutical companies, research organizations, and institutes in the regions, which are focused on finding a standard treatment for the condition.
The North America and Europe markets for scleroderma diagnostics and therapeutics are expected to retain their dominance in the global scleroderma diagnostics and therapeutics market throughout the forecast period, exhibiting CAGRs of 11.2% and 10.9%, respectively, over the period between 2016 and 2024. The ongoing cutting-edge research pertaining to scleroderma will aid the growth of a niche scleroderma diagnostics and therapeutics market in these regions.
Asia Pacific represents some of the world’s key emerging economies, which have the potential to adopt quickly to new therapies, provided they are available at reasonable costs. Due to the price-sensitive nature of the market, as well as availability of cheaper generics and reasonable clinical diagnostic rates compared to North America and Europe, the market for Asia Pacific gained the third position in terms of market share in 2015. The Asia Pacific market will also retain its position in the global market over the forecast period, with factors such as large population and high unmet needs working in favor of market expansion in the region.
Actelion Pharmaceuticals, Inc., Boehringer Ingelheim, Bayer AG, Cytori Therapeutics, Inc., Corbus Pharmaceutical Holdings Inc, Cumberland Pharmaceuticals, Inc., Gilead Sciences, Inc., Pfizer, Inc., and Sanofi are some of the key players operating in the global scleroderma diagnostics and therapeutics market.
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)